UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Providing a quality service: direct referral from the cytology laboratory to the colposcopy clinic

Journal of medical screening, 2005-01, Vol.12 (1), p.3-6

2005

Volltextzugriff (PDF)

Teaching self-injection to diabetics: An easier and more effective way

Nursing (Jenkintown, Pa.), 1984-01, Vol.14 (1), p.57-57

1984

Volltextzugriff (PDF)

The level of origin firing inversely affects the rate of replication fork progression

The Journal of cell biology, 2013-04, Vol.201 (3), p.373-383

2013

Volltextzugriff (PDF)

Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study

The lancet oncology, 2013-05, Vol.14 (6), p.461-471

2013

Volltextzugriff (PDF)

Experience and Activity-Dependent Maturation of Perisomatic GABAergic Innervation in Primary Visual Cortex during a Postnatal Critical Period

The Journal of neuroscience, 2004-10, Vol.24 (43), p.9598-9611

2004

Volltextzugriff (PDF)

Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer

The New England journal of medicine, 2012-01, Vol.366 (2), p.109-119

2012

Volltextzugriff (PDF)

Conditional expression of Parkinson's disease-related R1441C LRRK2 in midbrain dopaminergic neurons of mice causes nuclear abnormalities without neurodegeneration

Neurobiology of disease, 2014-11, Vol.71, p.345-358

2014

Volltextzugriff (PDF)

Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer

The New England journal of medicine, 2012-01, Vol.366 (2), p.109-119

2012

Volltextzugriff (PDF)

Timing of Initiation of Renal-Replacement Therapy in Acute Kidney Injury

The New England journal of medicine, 2020-07, Vol.383 (3), p.240-251

2020

Volltextzugriff (PDF)

GAD67-Mediated GABA Synthesis and Signaling Regulate Inhibitory Synaptic Innervation in the Visual Cortex

Neuron (Cambridge, Mass.), 2007-06, Vol.54 (6), p.889-903

2007

Volltextzugriff (PDF)

The Team Formulation Quality Rating Scale (TFQS): development and evaluation

Journal of mental health (Abingdon, England), 2021-02, Vol.30 (1), p.43-50

2021

Volltextzugriff (PDF)

Event-Free Survival in Patients with Early HER2-Positive Breast Cancer with a Pathological Complete Response after HER2-Targeted Therapy: A Pooled Analysis

Cancers, 2022-10, Vol.14 (20), p.5051

2022

Volltextzugriff (PDF)

Cardiac Tolerability of Pertuzumab Plus Trastuzumab Plus Docetaxel in Patients With HER2‐Positive Metastatic Breast Cancer in CLEOPATRA: A Randomized, Double‐Blind, Placebo‐Controlled Phase III Study

The oncologist (Dayton, Ohio), 2013-03, Vol.18 (3), p.257-264

2013

Volltextzugriff (PDF)

Serious negative consequences associated with exposure and response prevention for obsessive‐compulsive disorder: A survey of therapist attitudes and experiences

Depression and anxiety, 2020-05, Vol.37 (5), p.418-428

2020

Volltextzugriff (PDF)

Treatment of older patients with HER2-positive metastatic breast cancer with pertuzumab, trastuzumab, and docetaxel: subgroup analyses from a randomized, double-blind, placebo-controlled phase III trial (CLEOPATRA)

Breast cancer research and treatment, 2013-11, Vol.142 (1), p.89-99

2013

Volltextzugriff (PDF)

Safety Profile of Pertuzumab With Trastuzumab and Docetaxel in Patients From Asia With Human Epidermal Growth Factor Receptor 2‐Positive Metastatic Breast Cancer: Results From the Phase III Trial CLEOPATRA

The oncologist (Dayton, Ohio), 2014-07, Vol.19 (7), p.693-701

2014

Volltextzugriff (PDF)

The HEALing (Helping to End Addiction Long-term SM) Communities Study: Protocol for a cluster randomized trial at the community level to reduce opioid overdose deaths through implementation of an integrated set of evidence-based practices

Drug and alcohol dependence, 2020-12, Vol.217, p.108335-108335, Article 108335

2020

Volltextzugriff (PDF)

How can we deliver on the promise of precision medicine in oncology and beyond? A practical roadmap for action

Health science reports, 2023-06, Vol.6 (6), p.e1349-n/a

2023

Volltextzugriff (PDF)

Updates on radiotherapy-immunotherapy combinations: Proceedings of 6 th annual ImmunoRad conference

Oncoimmunology, 2023-12, Vol.12 (1), p.2222560

2023

Volltextzugriff (PDF)

Real-World First-Line Use of Pertuzumab With Different Taxanes for Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: A Comparative Effectiveness Study Using US Electronic Health Records

JCO oncology practice, 2023-07, Vol.19 (7), p.435-445

2023

Volltextzugriff (PDF)

Abstract P2-11-07: Association of PIK3CA mutations with efficacy in HER2-positive first-line metastatic breast cancer: a meta-analysis

Cancer research (Chicago, Ill.), 2023-03, Vol.83 (5_Supplement), p.P2-P2-11-07

2023

Volltextzugriff (PDF)

End-of-study analysis from the phase III, randomized, double-blind, placebo (Pla)-controlled CLEOPATRA study of first-line (1L) pertuzumab (P), trastuzumab (H), and docetaxel (D) in patients (pts) with HER2-positive metastatic breast cancer (MBC)

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.1020-1020

2019

Volltextzugriff (PDF)

Rapid Translation of COVID-19 Preprint Data into Critical Care Practice

American journal of respiratory and critical care medicine, 2021-02, Vol.203 (3), p.368-371

2021

Volltextzugriff (PDF)

The Australasian Resuscitation In Sepsis Evaluation: Fluids or vasopressors in emergency department sepsis (ARISE FLUIDS), a multi‐centre observational study describing current practice in Australia and New Zealand

Emergency medicine Australasia, 2020-08, Vol.32 (4), p.586-598

2020

Volltextzugriff (PDF)

Efficacy of trastuzumab emtansine (T-DM1) in patients (pts) with HER2+ metastatic breast cancer (MBC) previously treated with pertuzumab (P)

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.1023-1023

2017

Volltextzugriff (PDF)

1 – 25 von 48

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(46)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Providing a quality service: direct referral from the cytology laboratory to the colposcopy clinic

Teaching self-injection to diabetics: An easier and more effective way

The level of origin firing inversely affects the rate of replication fork progression

Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study

Experience and Activity-Dependent Maturation of Perisomatic GABAergic Innervation in Primary Visual Cortex during a Postnatal Critical Period

Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer

Conditional expression of Parkinson's disease-related R1441C LRRK2 in midbrain dopaminergic neurons of mice causes nuclear abnormalities without neurodegeneration

Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer

Timing of Initiation of Renal-Replacement Therapy in Acute Kidney Injury

GAD67-Mediated GABA Synthesis and Signaling Regulate Inhibitory Synaptic Innervation in the Visual Cortex

The Team Formulation Quality Rating Scale (TFQS): development and evaluation

Event-Free Survival in Patients with Early HER2-Positive Breast Cancer with a Pathological Complete Response after HER2-Targeted Therapy: A Pooled Analysis

Cardiac Tolerability of Pertuzumab Plus Trastuzumab Plus Docetaxel in Patients With HER2‐Positive Metastatic Breast Cancer in CLEOPATRA: A Randomized, Double‐Blind, Placebo‐Controlled Phase III Study

Serious negative consequences associated with exposure and response prevention for obsessive‐compulsive disorder: A survey of therapist attitudes and experiences

Treatment of older patients with HER2-positive metastatic breast cancer with pertuzumab, trastuzumab, and docetaxel: subgroup analyses from a randomized, double-blind, placebo-controlled phase III trial (CLEOPATRA)

Safety Profile of Pertuzumab With Trastuzumab and Docetaxel in Patients From Asia With Human Epidermal Growth Factor Receptor 2‐Positive Metastatic Breast Cancer: Results From the Phase III Trial CLEOPATRA

The HEALing (Helping to End Addiction Long-term SM) Communities Study: Protocol for a cluster randomized trial at the community level to reduce opioid overdose deaths through implementation of an integrated set of evidence-based practices

How can we deliver on the promise of precision medicine in oncology and beyond? A practical roadmap for action

Updates on radiotherapy-immunotherapy combinations: Proceedings of 6 th annual ImmunoRad conference

Real-World First-Line Use of Pertuzumab With Different Taxanes for Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: A Comparative Effectiveness Study Using US Electronic Health Records

Abstract P2-11-07: Association of PIK3CA mutations with efficacy in HER2-positive first-line metastatic breast cancer: a meta-analysis

End-of-study analysis from the phase III, randomized, double-blind, placebo (Pla)-controlled CLEOPATRA study of first-line (1L) pertuzumab (P), trastuzumab (H), and docetaxel (D) in patients (pts) with HER2-positive metastatic breast cancer (MBC)

Rapid Translation of COVID-19 Preprint Data into Critical Care Practice

The Australasian Resuscitation In Sepsis Evaluation: Fluids or vasopressors in emergency department sepsis (ARISE FLUIDS), a multi‐centre observational study describing current practice in Australia and New Zealand

Efficacy of trastuzumab emtansine (T-DM1) in patients (pts) with HER2+ metastatic breast cancer (MBC) previously treated with pertuzumab (P)

Suchergebnisse filtern